Synthon is a leading pharmaceutical company specializing in the development, manufacturing and commercialization of complex generic pharmaceuticals globally.
Enabling affordable
medicines globally
Synthon is a leading pharmaceutical company specializing in the development, manufacturing and commercialization of complex generic pharmaceuticals globally.
Enabling affordable
medicines globally
Synthon is a leading pharmaceutical company specializing in the development, manufacturing and commercialization of complex generic pharmaceuticals globally.
More than three decades of developing complex generics
Founded in 1991, Synthon has been a leader in the development, manufacture and commercialization of complex generics for more than three decades. With a focus on innovation, science and intellectual property to drive differentiation, Synthon has become the leading B2B player in the generics industry.
The development engine for the generics industry
As a science-driven leader, we combine our three strengths: Research & Development, Manufacturing and Commercialization to make complex generic medicines available at market formation globally.
Development
Best in class generics research and developmentDevelopment is the core of what we do. Utilizing innovative technologies, scientific rigour and a data driven approach, we invest to develop safe, effective affordable medicines.
Manufacturing
Reliable, vertically integrated manufacturing networkLeveraging our global manufacturing network including API and drug product sites, we provides our customers with high reliability in terms of service levels, security of supply and product quality.
Commercialization
Flexible business model to serve the needs of customers globallyOur core business is to serve as the leading Business to Business company working with partners to commercialize products globally. In select markets, we increase access to affordable medicines under the Synthon brand.
Global high-quality generics portfolio
Using the most advanced technologies, manufacturing processes and quality systems, Synthon has built an impressive portfolio of generic products across multiple therapy areas and dosage forms.
Committed to success
At Synthon, we take great pride in having the best team that is purpose driven, fully engaged and committed to your success.
A global company
Through careful expansion to meet customer needs and ensure high-quality generic medicines, our company has expanded its geographical footprint to operate as a global company, with local knowledge to serve our partners.
Read our latest news
Synthon will be joining EuroPLX in Cascais on 26th and 27th February 2024.
View 18 March, 2024DCAT in New YorkSynthon will be joining DCAT in New York on 18-21 March 2024.
View 15 April, 2024BePharmaSynthon will be joining BePharma in Mexico City on 15th and 16th April 2024.
View 17 April, 2024CPHI JapanSynthon will be joining CPHI Japan in Tokyo on 17-19 April 2024.
View 3 June, 2024EuroPLX in DublinSynthon will be joining EuroPLX in Dublin on 17-19 April 2024.
ViewWorking together for patients worldwide
Our mission is to create access to high-quality generic medicines for all patients. We believe in our trusted partnerships to achieve our goals. If you would like to discuss partnering opportunities, get in touch.